Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1217089.RAc9Ly0dNdTwwruPfhgWE5vKSxAI_UGrWrai9UCgM4LYQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1217089.RAc9Ly0dNdTwwruPfhgWE5vKSxAI_UGrWrai9UCgM4LYQ130_assertion type Assertion NP1217089.RAc9Ly0dNdTwwruPfhgWE5vKSxAI_UGrWrai9UCgM4LYQ130_head.
- NP1217089.RAc9Ly0dNdTwwruPfhgWE5vKSxAI_UGrWrai9UCgM4LYQ130_assertion description "[High GCS expression was significantly associated with poor differentiation (P = 0.01), lymph node metastasis (P = 0.004), recurrence/distant metastasis (P = 0.006), and chemotherapy resistance (P = 0.025).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217089.RAc9Ly0dNdTwwruPfhgWE5vKSxAI_UGrWrai9UCgM4LYQ130_provenance.
- NP1217089.RAc9Ly0dNdTwwruPfhgWE5vKSxAI_UGrWrai9UCgM4LYQ130_assertion evidence source_evidence_literature NP1217089.RAc9Ly0dNdTwwruPfhgWE5vKSxAI_UGrWrai9UCgM4LYQ130_provenance.
- NP1217089.RAc9Ly0dNdTwwruPfhgWE5vKSxAI_UGrWrai9UCgM4LYQ130_assertion SIO_000772 25189947 NP1217089.RAc9Ly0dNdTwwruPfhgWE5vKSxAI_UGrWrai9UCgM4LYQ130_provenance.
- NP1217089.RAc9Ly0dNdTwwruPfhgWE5vKSxAI_UGrWrai9UCgM4LYQ130_assertion wasDerivedFrom befree-2016 NP1217089.RAc9Ly0dNdTwwruPfhgWE5vKSxAI_UGrWrai9UCgM4LYQ130_provenance.
- NP1217089.RAc9Ly0dNdTwwruPfhgWE5vKSxAI_UGrWrai9UCgM4LYQ130_assertion wasGeneratedBy ECO_0000203 NP1217089.RAc9Ly0dNdTwwruPfhgWE5vKSxAI_UGrWrai9UCgM4LYQ130_provenance.